前收市價 | 39.26 |
開市 | 38.76 |
買盤 | 0.00 x 1100 |
賣出價 | 0.00 x 1300 |
今日波幅 | 38.47 - 39.09 |
52 週波幅 | 30.47 - 45.85 |
成交量 | |
平均成交量 | 7,497,977 |
市值 | 60.593B |
Beta 值 (5 年,每月) | 1.06 |
市盈率 (最近 12 個月) | 12.90 |
每股盈利 (最近 12 個月) | 3.01 |
業績公佈日 | 2024年7月17日 |
遠期股息及收益率 | 1.96 (5.05%) |
除息日 | 2024年3月27日 |
1 年預測目標價 | 47.20 |
U.S. Bancorp (USB) is gaining from an increase in total deposits balance. However, its escalated expense base continues to be a concern.
Novo Nordisk, TotalEnergies, U.S. Bancorp and Flanigan's are included in this Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), TotalEnergies SE (TTE) and U.S. Bancorp (USB), as well as a micro-cap stock Flanigan's Enterprises, Inc. (BDL).